Evidence map›Paper›PMID 32458634›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.

Harsh Goel, Saloni Singhal, Runjhun Mathur, Saima Syeda, Rishi Kumar Gupta, Anshuman Kumar, Anju Shrivastava, Abhimanyu Kumar Jha

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Harsh GoelDepartment of Biotechnology, Institute of Applied Medicines and Research Ghaziabad, Uttar Pradesh, India.
Saloni SinghalDepartment of Biotechnology, Institute of Applied Medicines and Research Ghaziabad, Uttar Pradesh, India.
Runjhun MathurDr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India.
Saima SyedaDepartment of Zoology, Delhi University, India.
Rishi Kumar GuptaSh. Jagannath Charitable Cancer Hospital, Ghaziabad, Uttar Pradesh, India.
Anshuman KumarDharamshila Cancer Hospital and Research Centre, New Delhi, India.
Anju ShrivastavaDepartment of Zoology, Delhi University, India.
Abhimanyu Kumar JhaDepartment of Biotechnology, Institute of Applied Medicines and Research Ghaziabad, Uttar Pradesh, India.
University of Delhi · INDr. A.P.J. Abdul Kalam Technical University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ABSTRACT<br />Large Tumor Suppressor (LATS2) gene are Tumor Suppressor gene, linked with epigenetic modifications. LATS2 promoter hypermethylation is an important epigenetic silencing mechanism leading to cancer. Cancer is the most common, vicious and dangerously increasing diseases of the world today, associated with high morbidity and mortality. Oral cancers (OC) are the blazing universal dilemma and is the sixth most frequent cancer observed in Indian population. Tobacco consumption is the main cause of the increase in OSCC. The association between LATS2 in the pathogenesis of cancers propose that their combination might be studied as a possible molecular marker for particular subgroups of patients. Therefore, the present study tried to investigate whether LATS2 promoter methylation was associated with oral squamous cell carcinoma (OSCC) in North Indian subjects. DNA methylation quantitative studies of LATS2 Tumor Suppressor genes were performed by methylation-specific polymerase chain reaction (MSP). 38 out of 70 patients (55 %) were found to be methylated for LATS2 gene, a statistically significant result was obtained (p-value < 0.005) for LATS2 genes. The results suggest that epigenetic changes may be related to the down-regulation of LATS2 expression. It can be concluded that LATS2 gene plays a significant role in the diagnosis of cancer and provide a better alternative as a diagnostic biomarker. Our data infer that a low LATS2 expression due to methylation may contribute to the cancer progression and could be useful for the diagnosis of OSCC. Therefore, investigation of promoter methylation in such genes may provide a biomarker which may prove to be useful in early detection of Oral Cancer.<br />Keywords: Oral squamous cell carcinoma (OSCC), Epigenetic changes, LATS2 gene, Promoter Hypermethylation, Methylation-Specific PCR (MSP), Biomarkers<br />Abbreviations: OSCC- Oral Squamous Cell Carcinoma; DNA- Deoxyribonucleic acid; LATS-Large Tumor Suppressor (gene); MSP-Methylation-Specific Polymerase Chain Reaction.

Indexed as

DNA MethylationGene Expression Regulation, NeoplasticPromoter Regions, GeneticBiomarkers, TumorCarcinoma, Squamous CellCase-Control StudiesEpigenesis, GeneticHumansMouth NeoplasmsPrognosisProtein Serine-Threonine KinasesTumor Cells, CulturedTumor Suppressor ProteinsBiomarkers, TumorLATS2 protein, humanProtein Serine-Threonine KinasesTumor Suppressor ProteinsBiomarkerEpigenetic changesKeywords: Oral squamous cell carcinoma (OSCC)Methylation-Specific PCR (MSP)Promoter hypermethylation

Identifiers

PMID32458634
PMCPMC7541850
OpenAlexW3031918318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.